Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Bj. Lund"'
Publikováno v:
Acta Medica Scandinavica. 205:73-78
Thirty-four patients were studied 2--6 years after jejunoileal bypass for morbid obesity. The serum concentration of 25-hydroxyvitamin D (25-OHD) were reduced and related to the frequency fo stools and to the weight reduction. Fifteen patients were n
Autor:
H. Yde, Lis Mosekilde, H. E. Nielsen, Bj. Lund, B. Jastrup, Ole Helmer Sørensen, Bi. Lund, Flemming Melsen
Publikováno v:
European Journal of Clinical Investigation. 14:96-102
The effect of propranolol 160-640 mg/day for 3 months on the accelerated loss of bone matrix and mineral in hyperthyroidism was studied in seventeen patients. A rise in serum thyroxine (P less than 0.01) during the first 3 weeks was followed by a fal
Myopathy in Bone Loss of Ageing: Improvement by Treatment with 1α-hydroxycholecalciferol and Calcium
Autor:
Flemming Melsen, Bj. Lund, Ole Helmer Sørensen, Lis Mosekilde, Bi. Lund, L. Hjorth, B. Saltin, R. B. Andersen
Publikováno v:
Clinical Science. 56:157-161
1. Eleven patients with the bone loss of ageing were treated with the vitamin D analogue 1α-hydroxycholecalciferol and calcium for 3–6 months. 2. Muscle biopsies were taken from the vastus lateralis before and after the treatment and the activity
Publikováno v:
Metabolism. 31:126-132
Serum levels of 25-hydroxyvitamin DF, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D were measured in 25 untreated hyperthyroid patients in whom histomorphometric evaluations of iliac crest bone biopsies were performed after in vivo tetracyclin
Publikováno v:
Calcified Tissue Research. 22:473-478
Autor:
H. E. Nielsen, Bj. Lund, Flemming Melsen, Ole Helmer Sørensen, K. Emmertsen, H. Sølling, Bi. Lund, H H Hansen, Lis Mosekilde
Publikováno v:
Metabolic Bone Disease and Related Research. 4:17-23
Fourteen patients with medullary carcinoma of the thyroid (MCT) and hypercalcitoninemia were studied. Serum concentrations of calcium, phosphorus and iPTH (C-terminal) were normal. Serum 1,25-dihydroxyvitamin D (1,25-(OH)2D) levels were increased (p
Autor:
O.H. Sørensen, I.B. Lumholtz, Bi. Lund, Hans-Henrik Parving, T.L. Storm, Andersen Ar, Christiansen Js, Bj. Lund
Publikováno v:
Metabolic Bone Disease and Related Research. 5:107-110
A significant loss of bone has been observed in diabetes mellitus. The patogenesis is unknown, but an impairment of vitamin D metabolism might be involved. Consequently, we have studied vitamin D metabolism in five groups of insulin-dependent diabeti
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 49:484-486
Fifteen acromegalic subjects were found to have elevated plasma levels of both 1,25(OH)2-vitamin D, 65 +/- 23 (SD) pg/ml [normal 33 + 15 pg/ml (SD)] and 24,25(OH)2-vitamin D, 6.8 +/- 1.6 (SD) ng/ml [normal 3.4 + 1.2 ng/ml (SD)]. Treatment with bromoc
Publikováno v:
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 10(6)
Vitamin D has been proposed as a risk factor of ischaemic heart disease. In 12 patients with acute myocardial infarction the major circulating vitamin D metabolite, 25-hydroxy-cholecalciferol (25-HCC), did not show any fluctuations during the first 4
Publikováno v:
Calcified tissue international. 34(1)
A 38-year-old woman, who 5 years earlier had undergone a jejunoileal bypass for gross obesity, fractured the distal forearm by a minor trauma. Circulating 25-hydroxycholecalciferol was undetactable without vitamin D3 supplement but increased to the l